Eli is a leader in the field of biotechnology, integrating innovation, software, DNA fabrication, and automation for bioproduct generation. He prides himself in the development of cutting edge scientific teams to conquer awesome scientific challenges. In addition, he excels in evaluating technologies in the context of current trends, future prospects, competitive landscape, products, and over all what works and what does not.
Prior to Autodesk, Eli’s experiences include production of a fatty alcohol from bioengineered E. coli and isobutanol from an engineered methanotroph. His technical expertise spans many aspects of biological engineering including expression optimization, enzyme evolution, genetic modification, high-throughput screening, bioprocess, and scale up to commercial operations. He received his PhD in Biophysics at the University of California, San Francisco.